Sabizabulin on "Short Path to FDA EMA", Will "Serve Critical Roles in the US and Abroad" - Veru (VERU) PT Hiked to $36 at Oppenheimer,

Go back to Sabizabulin on "Short Path to FDA EMA", Will "Serve Critical Roles in the US and Abroad" - Veru (VERU) PT Hiked to $36 at Oppenheimer,
(NASDAQ: VERU) Delayed: 2.79 +0.02 (0.72%)
Previous Close $2.77    52 Week High
Open $2.75    52 Week Low
Day High $2.83    P/E N/A 
Day Low $2.69    EPS
Volume 456,532